ALEC Stock Analysis: Buy, Sell, or Hold?
ALEC - Alector, Inc. Common Stock
$1.89
-0.02 (-1.05%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When ALEC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ALEC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ALEC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ALEC is currently trading at $1.89, which is considered slightly high relative to its 30-day fair value range of $1.56 to $1.92.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $1.76, while resistance sits at $2.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $1.76, while resistance sits at $2.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$1.56 -
$1.92
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($2.10)
Fair Price Analysis
30-Day Fair Range
$1.56 -
$1.92
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.77
Resistance Level
$2.00
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.01
Wall Street Target
$2.10
(+9.9%)
Revenue Growth (YoY)
-78.8%
Earnings Growth (YoY)
-86.3%
Profit Margin
-156.0%
Last updated: January 30, 2026 10:53 PM ET
Data refreshes hourly during market hours. Next update: 11:53 PM
Data refreshes hourly during market hours. Next update: 11:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALEC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Grace Wong-Sarad
SELL
5910 shares
2025-09-02
Paula Hammond
SELL
14000 shares
2025-08-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
Advanced ALEC Option Strategies
Professional options setups generated by AI based on today's ALEC price and gamma walls.
